[Treatment of vulvo-vaginal candidiasis with econazole (author's transl)].
In 2103 women with vulvo-vaginal candidiasis proved by culture, econazole (an antimycotic drug, also effective against gram-positive bacteria) was administered as vaginal cream (1077 patients) or in ovules (1026 patients). The cure rate for each method was about 90% one week after the end of treatment. Although each of the methods of administration contained the same amount of effective substance, the cure rate four weeks after end of treatment was higher for the ovules (90.3%) than the vaginal cream (86.5%).
D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy*; D002722:Chlorobenzenes / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D013997:Time Factors; D014622:Vaginal Creams, Foams, and Jellies; D014848:Vulvovaginitis / Q000188:drug therapy*
D000935:Antifungal Agents; D002722:Chlorobenzenes; D007093:Imidazoles; D014622:Vaginal Creams, Foams, and Jellies
Die vulvo-vaginale Mykose und ihre Behandlung mit Econazol